BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)
| 1.30 Delayed Data As of May 20 |  +0.01 / +0.78%Today’s Change | 1.00 Today|||52-Week Range 4.19 | -44.68% Year-to-Date |
Latest BVXV News | Press Releases
No recent news for BiondVax Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 1.29 |
| Today’s open | 1.30 |
| Day’s range | 1.30 - 1.30 |
| Volume | 1,052 |
| Average volume (3 months) | 937,953 |
| Market cap | $24.2M |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | -650.13% |
| Earnings growth (this year) | 0.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CHALFChalice Brands Ltd. | 0.00 | 0.00% |
| CDTXCidara Therapeutics ... | -0.02 | -4.74% |
| CYANCyanotech Corp | -0.09 | -3.12% |
| ---- |
Data as of 4:02pm ET, 05/20/2022
Financials
| Next reporting date | June 1, 2022 |
| EPS forecast (this quarter) | $0.00 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$12.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Jerusalem, Jerusalem |
Forecasts
